166 related articles for article (PubMed ID: 10318858)
1. The autonomous transactivation domain in helix H3 of the vitamin D receptor is required for transactivation and coactivator interaction.
Kraichely DM; Collins JJ; DeLisle RK; MacDonald PN
J Biol Chem; 1999 May; 274(20):14352-8. PubMed ID: 10318858
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor.
Liu YY; Nguyen C; Peleg S
Mol Endocrinol; 2000 Nov; 14(11):1776-87. PubMed ID: 11075811
[TBL] [Abstract][Full Text] [Related]
3. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN
Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066
[TBL] [Abstract][Full Text] [Related]
4. Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues.
Barry JB; Leong GM; Church WB; Issa LL; Eisman JA; Gardiner EM
J Biol Chem; 2003 Mar; 278(10):8224-8. PubMed ID: 12529369
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
[TBL] [Abstract][Full Text] [Related]
6. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
7. Identification of an autonomous transactivation domain in helix H3 of the vitamin D receptor.
Kraichely DM; Nakai YD; MacDonald PN
J Cell Biochem; 1999 Oct; 75(1):82-92. PubMed ID: 10462707
[TBL] [Abstract][Full Text] [Related]
8. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
[TBL] [Abstract][Full Text] [Related]
9. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
Herdick M; Steinmeyer A; Carlberg C
Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
[TBL] [Abstract][Full Text] [Related]
10. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.
Malloy PJ; Xu R; Peng L; Clark PA; Feldman D
Mol Endocrinol; 2002 Nov; 16(11):2538-46. PubMed ID: 12403843
[TBL] [Abstract][Full Text] [Related]
12. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
[TBL] [Abstract][Full Text] [Related]
13. Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts.
Thompson PD; Remus LS; Hsieh JC; Jurutka PW; Whitfield GK; Galligan MA; Encinas Dominguez C; Haussler CA; Haussler MR
J Mol Endocrinol; 2001 Oct; 27(2):211-27. PubMed ID: 11564604
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
15. A novel inborn error in the ligand-binding domain of the vitamin D receptor causes hereditary vitamin D-resistant rickets.
Malloy PJ; Zhu W; Zhao XY; Pehling GB; Feldman D
Mol Genet Metab; 2001 Jun; 73(2):138-48. PubMed ID: 11386849
[TBL] [Abstract][Full Text] [Related]
16. 20-Epi analogues of 1,25-dihydroxyvitamin D3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D3 receptor.
Yang W; Freedman LP
J Biol Chem; 1999 Jun; 274(24):16838-45. PubMed ID: 10358028
[TBL] [Abstract][Full Text] [Related]
17. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function.
Malloy PJ; Xu R; Peng L; Peleg S; Al-Ashwal A; Feldman D
Endocrinology; 2004 Nov; 145(11):5106-14. PubMed ID: 15308610
[TBL] [Abstract][Full Text] [Related]
18. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1.
Gill RK; Atkins LM; Hollis BW; Bell NH
Mol Endocrinol; 1998 Jan; 12(1):57-65. PubMed ID: 9440810
[TBL] [Abstract][Full Text] [Related]
19. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
Solomon C; Macoritto M; Gao XL; White JH; Kremer R
J Bone Miner Res; 2001 Jan; 16(1):39-45. PubMed ID: 11149488
[TBL] [Abstract][Full Text] [Related]
20. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation.
Whitfield GK; Hsieh JC; Nakajima S; MacDonald PN; Thompson PD; Jurutka PW; Haussler CA; Haussler MR
Mol Endocrinol; 1995 Sep; 9(9):1166-79. PubMed ID: 7491109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
